Genome sequencing of strains of the most prevalent clonal group of O1:K1:H7 Escherichia coli that causes neonatal meningitis in France.
Amoeba model
Escherichia coli
Meningitis
Newborns
Sequencing data analysis
Journal
BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981
Informations de publication
Date de publication:
17 01 2019
17 01 2019
Historique:
received:
26
06
2018
accepted:
18
12
2018
entrez:
19
1
2019
pubmed:
19
1
2019
medline:
24
9
2019
Statut:
epublish
Résumé
To describe the temporal dynamics, molecular characterization, clinical and ex vivo virulence of emerging O1:K1 neonatal meningitis Escherichia coli (NMEC) strains of Sequence Type complex (STc) 95 in France. The national reference center collected NMEC strains and performed whole genome sequencing (WGS) of O1:K1 STc95 NMEC strains for phylogenetic and virulence genes content analysis. Data on the clinical and biological features of patients were also collected. Ex vivo virulence was assessed using the Dictyostelium discoideum amoeba model. Among 250 NMEC strains collected between 1998 and 2015, 38 belonged to O1:K1 STc95. This clonal complex was the most frequently collected after 2004, representing up to 25% of NMEC strains in France. Phylogenetic analysis demonstrated that most (74%) belonged to a cluster designated D-1, characterized by the adhesin FimH30. There is no clinical data to suggest that this cluster is more pathogenic than its counterparts, although it is highly predominant and harbors a large repertoire of extraintestinal virulence factors, including a pS88-like plasmid. Ex vivo virulence model showed that this cluster was generally less virulent than STc95 reference strains of O45 The emerging clonal group O1:K1 STc95 of NMEC strains is mainly composed of a cluster with many virulence factors but of only moderate virulence. Whether its emergence is due to its ability to colonize the gut thanks to FimH30 or pS88-like plasmid remains to be determined.
Sections du résumé
BACKGROUND
To describe the temporal dynamics, molecular characterization, clinical and ex vivo virulence of emerging O1:K1 neonatal meningitis Escherichia coli (NMEC) strains of Sequence Type complex (STc) 95 in France. The national reference center collected NMEC strains and performed whole genome sequencing (WGS) of O1:K1 STc95 NMEC strains for phylogenetic and virulence genes content analysis. Data on the clinical and biological features of patients were also collected. Ex vivo virulence was assessed using the Dictyostelium discoideum amoeba model.
RESULTS
Among 250 NMEC strains collected between 1998 and 2015, 38 belonged to O1:K1 STc95. This clonal complex was the most frequently collected after 2004, representing up to 25% of NMEC strains in France. Phylogenetic analysis demonstrated that most (74%) belonged to a cluster designated D-1, characterized by the adhesin FimH30. There is no clinical data to suggest that this cluster is more pathogenic than its counterparts, although it is highly predominant and harbors a large repertoire of extraintestinal virulence factors, including a pS88-like plasmid. Ex vivo virulence model showed that this cluster was generally less virulent than STc95 reference strains of O45
CONCLUSIONS
The emerging clonal group O1:K1 STc95 of NMEC strains is mainly composed of a cluster with many virulence factors but of only moderate virulence. Whether its emergence is due to its ability to colonize the gut thanks to FimH30 or pS88-like plasmid remains to be determined.
Identifiants
pubmed: 30654756
doi: 10.1186/s12866-018-1376-4
pii: 10.1186/s12866-018-1376-4
pmc: PMC6337857
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17Références
Appl Environ Microbiol. 2012 Aug;78(16):5824-30
pubmed: 22706051
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8922-6
pubmed: 9671780
Int J Med Microbiol. 2005 Oct;295(6-7):373-81
pubmed: 16238014
BMC Microbiol. 2015 Oct 14;15:211
pubmed: 26467858
Pediatr Infect Dis J. 2011 Mar;30(3):212-7
pubmed: 21416693
Infect Immun. 2005 May;73(5):2923-31
pubmed: 15845498
Nat Rev Microbiol. 2010 Jan;8(1):26-38
pubmed: 19966814
J Infect Dis. 2003 Jun 15;187(12):1895-906
pubmed: 12792866
Nat Rev Neurosci. 2003 May;4(5):376-85
pubmed: 12728265
Infect Immun. 2009 Jun;77(6):2272-84
pubmed: 19307211
Infect Immun. 1990 Jun;58(6):1995-8
pubmed: 1971261
J Clin Microbiol. 2012 Apr;50(4):1355-61
pubmed: 22238442
Appl Environ Microbiol. 2007 Apr;73(7):2373-7
pubmed: 17293507
mSphere. 2017 May 31;2(3):
pubmed: 28593194
J Infect Dis. 2006 Oct 15;194(8):1141-50
pubmed: 16991090
mBio. 2016 Mar 22;7(2):e02162
pubmed: 27006459
BMJ. 2001 Sep 8;323(7312):533-6
pubmed: 11546697
Clin Infect Dis. 2015 Sep 1;61(5):779-86
pubmed: 25944342
J Med Microbiol. 2017 Sep;66(9):1350-1357
pubmed: 28825894
Nat Rev Microbiol. 2010 Mar;8(3):207-17
pubmed: 20157339
PLoS One. 2010 Aug 11;5(8):e11882
pubmed: 20711443
J Clin Microbiol. 2014 May;52(5):1501-10
pubmed: 24574290
Infect Immun. 1983 Mar;39(3):1136-41
pubmed: 6341228
Brief Bioinform. 2008 Jul;9(4):299-306
pubmed: 18417537